NCT02645240

Brief Summary

The study aims to identify several factors that can accurately predict the incident of intestinal infraction in patients with mesenteric vascular occlusion or ischemia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
97

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Oct 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2015

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 29, 2015

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 1, 2016

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2017

Completed
Last Updated

August 29, 2017

Status Verified

August 1, 2017

Enrollment Period

1.8 years

First QC Date

December 29, 2015

Last Update Submit

August 28, 2017

Conditions

Mesenteric Ischemia

Outcome Measures

Primary Outcomes (1)

  • Clinical improvement

    Number of patients with resolved abdominal symptoms and incidence of patients developing shock

    48 hours

Study Arms (1)

Heparin injection

EXPERIMENTAL

Injection of low molecular weight heparin in patients with acute mesenteric ischemia to assess outcome

Drug: Heparin injection

Interventions

Heparin injectionDRUG

Intravenous heparin injection in patients with acute mesenteric ischemia and evaluating their response within 24 hours

Also known as: Low molecular weight heparin injection
Heparin injection

Eligibility Criteria

Age16 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with acute mesenteric Ischemia

You may not qualify if:

  • Patients with other causes of acute abdomen other than mesenteric Ischemia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mansoura university hospital

Al Mansurah, Dakahlia Governorate, Egypt

Location

MeSH Terms

Conditions

Mesenteric Ischemia

Interventions

HeparinHeparin, Low-Molecular-Weight

Condition Hierarchy (Ancestors)

Intestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesPeritoneal DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

GlycosaminoglycansPolysaccharidesCarbohydrates

Study Officials

  • Sameh H Emile, M.D

    Mansoura Univesity

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 29, 2015

First Posted

January 1, 2016

Study Start

October 1, 2015

Primary Completion

July 1, 2017

Study Completion

August 1, 2017

Last Updated

August 29, 2017

Record last verified: 2017-08

Locations

EG(1)